Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to treat arthritis. The
purpose of this study is to test the effectiveness of flavocoxid, a plant-derived compound,
for the treatment of knee osteoarthritis (OA) in adults.
Study hypotheses: 1) Flavocoxid has an acceptable safety and tolerability profile as
determined by the Generally Regarded as Safe (GRAS) profile in patients with OA compared to
identical placebo. 2) Flavocoxid will be more effective as a therapy for OA compared to
identical placebo.
Phase:
Phase 1
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborators:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Primus Pharmaceuticals